Merck donated 300,000 masks to New Jersey for COVID-19 emergency response
On Mar. 25, 2020, Merck announced it had donated 300,000 masks to New Jersey’s Office of Homeland Security…
-
-
New COVID-19 assay adapted to run on T2 Biosystems’ FDA-cleared T2Dx Instrument
On Mar. 24, 2020, T2 Biosystems announced it had entered into a worldwide licensing agreement for a rapid…
-
U of A research projects shared $58 million in federal funding
On Mar. 24, 2020, the University of Alberta (U of A) announced that a Public health study was…
-
3M partnered with Ford to help further accelerate COVID-19 response
On Mar. 24, 2020, 3M and Ford Motor Co. announced that they had entered into a partnership in…
-
Bausch Health donated products and supplies in response to COVID-19 pandemic
On Mar. 24, 2020, Bausch Health announced it had donated medicines and health care products to assist in…
-
FDA provided Emergency Use Authorization to PerkinElmer for COVID-19 testing
On Mar. 24, 2020, PerkinElmer announced the U.S. Food and Drug Administration (FDA) had provided Emergency Use Authorization…
-
Patients with severe Coronavirus disease could offer clues to treatment
On Mar. 24, 2020, an international project aimed to enroll 500 COVID-19 patients to search for genetic mutations…
-
bioMerieux received FDA Emergency Use Authorization for BIOFIRE COVID-19 test
On Mar. 24, 2020, bioMerieux announced that BioFire Diagnostics, its subsidiary specialized in syndromic infectious disease testing, had…
-
Dynavax and Clover Biopharmaceuticals announced COVID-19 research collaboration
On Mar. 24, 2020, Dynavax Technologies and Clover Biopharmaceuticals, a China-based global clinical-stage biotechnology company, announced a research…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | NIH
Mesa Biotech received Emergency Use Authorization from FDA for 30 minute point of Care molecular COVID-19 test
On Mar. 24, 2020, Mesa Biotech announced it had received Emergency Use Authorization (EUA) from the U.S. Food…
-
Biotechnology | COVID-19 | Diagnostics | Disease | Infectious Disease | Pharmaceutical | Therapeutics
BioSig subsidiary NeuroClear acquired license for a broad-spectrum anti-viral agent that may treat COVID-19
On Mar. 24, 2020, BioSig Technologies announced that its majority-owned subsidiary NeuroClear Technologies, acquired the rights to develop a…
-
UNMC/Nebraska Medicine pioneering method to reuse personal protective equipment
On Mar. 24, 2020, Nebraska Medicine has developed a safe and effective method to decontaminate single-use personal protective…
-
BioReference Laboratories and City of Miami provided testing for Coronavirus Disease 2019
On Mar. 24, 2020, BioReference Laboratories, an OPKO Health company, announced a collaboration with the City of Miami…
-
Emerald Organic and Todos Medicalfor JV to supply US with COVID-19 rapid point-of-care testing kits
On Mar. 24, 2020, Emerald Organic Products and Todos Medical announced the creation of Corona Diagnostics, a joint…
-
$1.6 million gift from Morris-Singer Foundation established COVID-19 hotline and telemedicine services for primary care
On Mar. 24, 2020, the Andrew and Corey Morris-Singer Foundation donated $1.6 million to OHSU to support the…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Therapeutics
Windtree announced clinical study of lung injury treatment in COVID-19 patients with its KL4 surfactant therapy
On Mar. 24, 2020, Windtree Therapeutics announced it will study its proprietary KL4 surfactant to potentially mitigate the…
-
T2 Biosystems announced worldwide licensing agreement of COVID-19, novel Coronavirus assay
On Mar. 24, 2020, T2 Biosystems announced it has entered into a worldwide licensing agreement for a rapid…
-
Biotechnology | Diagnostics | Medicine | NIH | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics
The Simmons Cancer Center joined elite National Comprehensive Cancer Network
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
-
Resverlogix invited collaborations for use of Apabetalone in trials and studies to Combat spread of COVID-19
On Mar. 23, 2020, Resverlogix announced that it was seeking to collaborate with organizations currently testing therapies for…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics | U.S. Congress | Vaccine
NIH online resources support COVID-19 workers training to protect their own health
On Mar. 23, 2020, the National Institutes of Health (NIH) announced that it had launched an important online…
-
UK launched whole genome sequence alliance to map spread of coronavirus
On Mar. 23, 2020, the UK Government announced funding of £20 million to support clinicians and scientists in…
-
Amgen Foundation committed up to $12.5 million to support COVID-19 relief efforts
On Mar. 23, 2020, the Amgen Foundation announced an initial commitment of up to $12.5 million to support…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science History | Non-Profit Research | Therapeutics
Acura Pharmaceuticals provides an update on the development of LTX-03
On Mar. 23, 2020, Acura Pharmaceuticals announced that Abuse Deterrent Pharma, its licensee of LTX-03 (Hydrocodone Bitartrate and…
-
Harvard Bioscience introduced next generation inhalation system to aid in fight against COVID-19
On Mar. 23, 2020, Harvard Bioscience announced that it had launched an innovative technology – known as Accumulated…
-
serum therapy used as possible COVID-19 treatment
On Mar. 23, 2020, researchers at Washington University School of Medicine in St. Louis announced they were investigating…
-
LabCorp developing options to prioritize COVID-19 testing for inpatient population
On Mar. 23, 2020, LabCorp announced that it was exploring all options to prioritize COVID-19 testing for the…
-
BioReference Laboratories and City of Detroit provide testing for Coronavirus disease 2019
On Mar. 23, 2020, BioReference Labs, an OPKO Health company, announced a collaboration with the City of Detroit…
-
CSL Group to help battle Coronavirus
On Mar. 23, 2020, CSL announced that it was exploring development of a hyperimmune serum that could be…
-
Mount Sinai developing an ‘end-to-end’ diagnostics solution for COVID-19
On Mar. 23, 2020, an expert team of researchers and clinicians in microbiology, virology, pathology, molecular science, and…
-
Philips ramped up production of critical health technology products in response to COVID-19 pandemic
On Mar. 22, 2020, Royal Philips announced that it is increasing the production of certain critical care products and…
